Experimental drug reverses high cholesterol, obesity-related nonalcoholic fatty liver disease in animal study
Scientists have discovered a novel molecular pathway for an enzyme inhibitor in humans that plays a direct role in the development of high cholesterol and nonalcoholic fatty liver disease, which they then were able to reverse ...
Mar 25, 2019